OnPoint OsteoCentric Funding III LP — Form D
OnPoint OsteoCentric Funding III LP of DALLAS, TX, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-12-01. $3.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2020-12-01
- Form: D
- Accession: 0001834120-20-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $3.2M
- Investors: 12
- Date of first sale: 2020-11-16
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-381901
Issuer
- Name: OnPoint OsteoCentric Funding III LP
- CIK: 0001834120
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3613 Cedar Lane, DALLAS, TX, 75234
- Phone: 214-499-2622
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Todd NA Travers | Executive Officer | Dallas, TX |
| Reed NA Williams | Executive Officer | Dallas, TX |
| N/A NA OnPoint Advisors, LLC | Promoter | Dallas, TX |
| N/A NA OnPoint Companies, LLC | Promoter | Dallas, TX |
More